Structural studies of amyloid proteins at the molecular level

Annual Review of Biochemistry

Volumn 86, Issue , 2017, Pages 69-95

  Eisenberg, David S ^a   Sawaya, Michael R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid symmetry; Cryo electron microscopy; Cryo EM; Polymorphs; Solid state nuclear magnetic resonance; SsNMR; Steric zipper; X ray diffraction

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PROTEIN; ASPARAGINE; GLUTAMINE; OLIGOMER; PRION PROTEIN; SERINE; THREONINE; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; ELECTRON DIFFRACTION; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SOLID STATE NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION; ANIMAL; CHEMISTRY; CRYOELECTRON MICROSCOPY; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PROTEIN DENATURATION; PROTEIN MOTIF; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEINOSIS;

AMINO ACID MOTIFS; AMYLOIDOGENIC PROTEINS; ANIMALS; CRYOELECTRON MICROSCOPY; GENE EXPRESSION; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRION PROTEINS; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN DENATURATION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; X-RAY DIFFRACTION;

EID: 85019910780     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-061516-045104     Document Type: Article

References (100)

1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, et al. (2014). Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21(4): 221-24
2. Astbury WT, Dickinson S, Bailey K. (1935). The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem. J. 29(10): 2351-60.1
3. Pauling L, Corey RB. (1951). Configurations of polypeptide chainswith favored orientations around single bonds: two new pleated sheets. PNAS 37(11): 729-40
4. Nelson R, Sawaya MR, Balbirnie M, Madsen Aø, Riekel C, et al. (2005). Structure of the cross-βspine of amyloid-like fibrils. Nature 435(7043): 773-78
5. Cohen AS, Calkins E. (1959). Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183(4669): 1202-3
6. Eanes ED, Glenner GG. (1968). X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16(11): 673-77
7. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC. (1997). Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273(3): 729-39
8. Hardy J, Selkoe DJ. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580): 353-56
9. Goedert M, Spillantini MG. (2006). A century of Alzheimer's disease. Science 314(5800): 777-81
10. Perrin RJ, Fagan AM, Holtzman DM. (2009). Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461(7266): 916-22
11. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, et al. (1988). Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23(2): 138-44
12. Harper JD, Wong SS, Lieber CM, Lansbury PT. (1997). Observation ofmetastable Aβamyloid protofibrils by atomic force microscopy. Chem. Biol. 4(2): 119-25
13. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. (1997). Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate. J. Biol. Chem. 272(35): 22364-72
14. Nag S, Sarkar B, Chandrakesan M, Abhyanakar R, Bhowmik D, et al. (2013). A folding transition underlies the emergence of membrane affinity in amyloid-β. Phys. Chem. Chem. Phys. 15(44): 19129-33
15. Benilova I, Karran E, De Strooper B. (2012). The toxic Aâoligomer and alzheimer's disease: An emperor in need of clothes. Nat. Neurosci. 15(3): 349-57
16. Lorenzo A, Yankner BA. (1994). β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. PNAS 91(25): 12243-47
17. Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, et al. (2011). In vivo demonstration thatα-synuclein oligomers are toxic. PNAS 108(10): 4194-99
18. Pieri L, Madiona K, Bousset L, Melki R. (2012). Fibrillar α-synuclein and Huntingtin exon 1 assemblies are toxic to the cells. Biophys. J. 102(12): 2894-905
19. Abedini A, Plesner A, Cao P, Ridgway Z, Zhang J, et al. (2016). Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics. eLife 5: e12977
20. Ikenoue T, Lee Y-H, Kardos J, Saiki M, Yagi H, et al. (2014). Cold denaturation of α-synuclein amyloid fibrils. Angew. Chem. Int. Ed. Engl. 53(30): 7799-804
21. Buell AK, Dobson CM, Knowles TPJ. (2014). The physical chemistry of the amyloid phenomenon: thermodynamics and kinetics of filamentous protein aggregation. Essays Biochem. 56: 11-39
22. Gustavsson A, Engström U, Westermark P. (1991). Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem. Biophys. Res. Commun. 175(3): 1159-64
23. Colon W, Kelly JW. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31(36): 8654-60
24. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, et al. (1997). Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385(6619): 787-93
25. Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. (1998). Amyloid fibril formation by an SH3 domain. PNAS 95(8): 4224-28
26. Fändrich M, Fletcher MA, Dobson CM. (2001). Amyloid fibrils from muscle myoglobin. Nature 410(6825): 165-66
27. Fändrich M, Dobson CM. (2002). The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 21(21): 5682-90
28. Goldschmidt L, Teng PK, Riek R, Eisenberg D. (2010). Identifying the amylome, proteins capable of forming amyloid-like fibrils. PNAS 107(8): 3487-92
29. Otzen D. (2010). Functional amyloid: turning swords into plowshares. Prion 4(4): 256-64
30. Pham CLL, Kwan AH, Sunde M. (2014). Functional amyloid: widespread in nature, diverse in purpose. Essays Biochem. 56: 207-19
31. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, et al. (2002). Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295(5556): 851-55
32. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, et al. (2009). Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325(5938): 328-32
33. Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. (2006). Functional amyloid formation within mammalian tissue. PLOS Biol. 4(1): e6
34. Kato M, Han TW, Xie S, Shi K, Du X, et al. (2012). Cell-free formation ofRNAgranules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell 149(4): 753-67
35. Si K, Lindquist S, Kandel ER. (2003). A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115(7): 879-91
36. Knowles TPJ, Buehler MJ. (2011). Nanomechanics of functional and pathological amyloid materials. Nat. Nanotechnol. 6(8): 469-79
37. Li D, Furukawa H, Deng H, Liu C, Yaghi OM, Eisenberg DS. (2014). Designed amyloid fibers as materials for selective carbon dioxide capture. PNAS 111(1): 191-96
38. Balbirnie M, Grothe R, Eisenberg DS. (2001). An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid. PNAS 98(5): 2375-80
39. Bowie JU, Lüthy R, Eisenberg D. (1991). A method to identify protein sequences that fold into a known three-dimensional structure. Science 253(5016): 164-70
40. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, Eisenberg D. (2006). The 3D profile method for identifying fibril-forming segments of proteins. PNAS 103(11): 4074-78
41. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. (2007). Atomic structures of amyloid cross-βspines reveal varied steric zippers. Nature 447(7143): 453-57
42. Wiltzius JJW, Landau M, Nelson R, Sawaya MR, Apostol MI, et al. (2009). Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 16(9): 973-78
43. Wiltzius JJW, Sievers SA, Sawaya MR, Eisenberg D. (2009). Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci. 18(7): 1521-30
44. Apostol MI, Sawaya MR, Cascio D, Eisenberg D. (2010). Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease. J. Biol. Chem. 285(39): 29671-75
45. Apostol MI, Wiltzius JJW, Sawaya MR, Cascio D, Eisenberg D. (2011). Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry 50(13): 2456-63
46. Landau M, Sawaya MR, Faull KF, Laganowsky A, Jiang L, et al. (2011). Towards a pharmacophore for amyloid. PLOS Biol. 9(6): e1001080
47. Colletier J-P, Laganowsky A, Landau M, Zhao M, Soriaga AB, et al. (2011). Molecular basis for amyloid-β polymorphism. PNAS 108(41): 16938-43
48. Ivanova MI, Sievers SA, Guenther EL, Johnson LM, Winkler DD, et al. (2014). Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. PNAS 111(1): 197-201
49. Liu C, Zhao M, Jiang L, Cheng P-N, Park J, et al. (2012). Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates. PNAS 109(51): 20913-18
50. Soriaga AB, Sangwan S, Macdonald R, Sawaya MR, Eisenberg D. (2016). Crystal structures of IAPP amyloidogenic segments reveal a novel packing motif of out-of-register beta sheets. J. Phys. Chem. B 120(26): 5810-16
51. Soragni A, Janzen DM, Johnson LM, Lindgren AG, Thai-Quynh Nguyen A, et al. (2016). A designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas. Cancer Cell 29(1): 90-103
52. Roland BP, Kodali R, Mishra R, Wetzel R. (2013). A serendipitous survey of prediction algorithms for amyloidogenicity. Biopolymers 100(6): 780-89
53. Tycko R. (2011). Solid-state NMR studies of amyloid fibril structure. Annu. Rev. Phys. Chem. 62: 279-99
54. Paravastu AK, Qahwash I, Leapman RD, Meredith SC, Tycko R. (2009). Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. PNAS 106(18): 7443-48
55. Bai X, McMullan G, Scheres SHW. (2015). How cryo-EM is revolutionizing structural biology. Trends Biochem. Sci. 40(1): 49-57
56. Tsemekhman K, Goldschmidt L, Eisenberg D, Baker D. (2007). Cooperative hydrogen bonding in amyloid formation. Protein Sci. 16(4): 761-64
57. Lawrence MC, Colman PM. (1993). Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234(4): 946-50
58. Stroud JC. (2013). The zipper groups of the amyloid state of proteins. Acta Crystallogr. Sect.D69(Pt 4): 540-45
59. White HE, Hodgkinson JL, Jahn TR, Cohen-Krausz S, Gosal WS, et al. (2009). Globular tetramers of β2-microglobulin assemble into elaborate amyloid fibrils. J. Mol. Biol. 389(1): 48-57
60. Fitzpatrick AWP, Debelouchina GT, Bayro MJ, Clare DK, Caporini MA, et al. (2013). Atomic structure and hierarchical assembly of a cross-βamyloid fibril. PNAS 110(14): 5468-73
61. Jiménez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, Saibil HR. (2002). The protofilament structure of insulin amyloid fibrils. PNAS 99(14): 9196-9201
62. Jiménez JL, Guijarro JI, Orlova E, Zurdo J, Dobson CM, et al. (1999). Cryo-electronmicroscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18(4): 815-21
63. Chou KC, Pottle M, Némethy G, Ueda Y, Scheraga HA. (1982). Structure ofβ-sheets: origin of the righthanded twist and of the increased stability of antiparallel over parallel sheets. J. Mol. Biol. 162(1): 89-112
64. Wälti MA, Ravotti F, Arai H, Glabe CG, Wall JS, et al. (2016). Atomic-resolution structure of a diseaserelevant Aβ(1-42) amyloid fibril. PNAS 113(34): e4976-84
65. Colvin MT, Silvers R, Ni QZ, Can TV, Sergeyev IV, et al. (2016). Atomic resolution structure of monomorphic Aβ42 amyloid fibrils. J. Am. Chem. Soc. 138(30): 9663-74
66. Tuttle MD, Comellas G, Nieuwkoop AJ, Covell DJ, Berthold DA, et al. (2016). Solid-stateNMRstructure of a pathogenic fibril of full-length human α-synuclein. Nat. Struct. Mol. Biol. 23(5): 409-15
67. Van Melckebeke H, Wasmer C, Lange A, Ab E, Loquet A, et al. (2010). Atomic-resolution threedimensional structure of HET-s(218-289) amyloid fibrils by solid-state NMR spectroscopy. J. Am. Chem. Soc. 132(39): 13765-75
68. Liu C, Sawaya MR, Eisenberg D. (2011). B2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages. Nat. Struct. Mol. Biol. 18(1): 49-55
69. Mehta AK, Lu K, Childers WS, Liang Y, Dublin SN, et al. (2008). Facial symmetry in protein selfassembly. J. Am. Chem. Soc. 130(30): 9829-35
70. Liang C, Ni R, Smith JE, Childers WS, Mehta AK, Lynn DG. (2014). Kinetic intermediates in amyloid assembly. J. Am. Chem. Soc. 136(43): 15146-49
71. O'Nuallain B, Williams AD, Westermark P, Wetzel R. (2004). Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279(17): 17490-99
72. Petkova AT, Leapman RD, Guo Z, Yau W-M, Mattson MP, Tycko R. (2005). Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307(5707): 262-65
73. Petkova AT, YauW-M, Tycko R. (2006). Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry 45(2): 498-512
74. Paravastu AK, Leapman RD, Yau W-M, Tycko R. (2008). Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils. PNAS 105(47): 18349-54
75. Schütz AK, Vagt T, Huber M, Ovchinnikova OY, Cadalbert R, et al. (2015). Atomic-resolution threedimensional structure of amyloid β fibrils bearing the Osaka mutation. Angew. Chem. Int. Ed. Engl. 54(1): 331-35
76. Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, et al. (2015). Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease. Nat. Struct. Mol. Biol. 22(6): 499-505
77. Schmidt M, Rohou A, Lasker K, Yadav JK, Schiene-Fischer C, et al. (2015). Peptide dimer structure in an Aβ(1-42) fibril visualized with cryo-EM. PNAS 112(38): 11858-63
78. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. (1997). α-Synuclein in Lewy bodies. Nature 388(6645): 839-40
79. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997). Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276(5321): 2045-47
80. Bodles AM, Guthrie DJ, Greer B, Irvine GB. (2001). Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity. J. Neurochem. 78(2): 384-95
81. Giasson BI, Murray IV, Trojanowski JQ, Lee VM. (2001). A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276(4): 2380-86
82. Rodriguez JA, Ivanova MI, Sawaya MR, Cascio D, Reyes FE, et al. (2015). Structure of the toxic core of α-synuclein from invisible crystals. Nature 525(7570): 486-90
83. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. (2004). Conformational variations in an infectious protein determine prion strain differences. Nature 428(6980): 323-28
84. Rodriguez JA, Jiang L, Eisenberg D. (2017). Toward the atomic structure of PrPSc. Cold Spring Harb. Perspect. Biol. In press
85. Safar J, Wille H, Itri V, Groth D, Serban H, et al. (1998). Eight prion strains have PrPSc molecules with different conformations. Nat. Med. 4(10): 1157-65
86. Jarrett JT, Lansbury PT. (1993). Seeding one-dimensional crystallization of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73(6): 1055-58
87. Prusiner SB. (2012). A unifying role for prions in neurodegenerative diseases. Science 336(6088): 1511-13
88. Aguzzi A, Rajendran L. (2009). The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64(6): 783-90
89. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, et al. (2012). Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109): 949-53
90. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI. (2012). Trans-cellular propagation of tau aggregation by fibrillar species. J. Biol. Chem. 287(23): 19440-51
91. Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, et al. (2010). Peripherally applied Aβ-containing inoculates induce cerebral β-amyloidosis. Science 330(6006): 980-82
92. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300(5618): 486-89
93. Fändrich M. (2012). Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. J. Mol. Biol. 421(4-5): 427-40
94. Haass C, Selkoe DJ. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8(2): 101-12
95. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, et al. (2005). Themost infectious prion protein particles. Nature 437(7056): 257-61
96. Laganowsky A, Liu C, Sawaya MR, Whitelegge JP, Park J, et al. (2012). Atomic view of a toxic amyloid small oligomer. Science 335(6073): 1228-31
97. Stroud JC, Liu C, Teng PK, Eisenberg D. (2012). Toxic fibrillar oligomers of amyloid-β have cross-β structure. PNAS 109(20): 7717-22
98. Gu L, Liu C, Stroud JC, Ngo S, Jiang L, Guo Z. (2014). Antiparallel triple-strand architecture for prefibrillar Aβ42 oligomers. J. Biol. Chem. 289(39): 27300-313
99. Kishimoto A, Hasegawa K, Suzuki H, Taguchi H, Namba K, Yoshida M. (2004). β-Helix is a likely core structure of yeast prion Sup35 amyloid fibers. Biochem. Biophys. Res. Commun. 315(3): 739-45
100. Krotee P, Rodriguez JA, Sawaya MR, Cascio D, Reyes FE, et al. (2017). Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity. eLife 6: e19273